Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 135

Results For "IDA"

1801 News Found

Iktos and Teijin Pharma to co-develop technology for small molecule drug discovery
Biotech | April 06, 2022

Iktos and Teijin Pharma to co-develop technology for small molecule drug discovery

Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process


ENTOD Pharma bullish on Macushield sales
News | April 06, 2022

ENTOD Pharma bullish on Macushield sales

Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision


Alvotech and STADA pave way to launching Hukyndra
Biotech | April 06, 2022

Alvotech and STADA pave way to launching Hukyndra

All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved


Alzamend Neuro appoints Dr. Terri Hunter to its Scientific Advisory Board
People | April 05, 2022

Alzamend Neuro appoints Dr. Terri Hunter to its Scientific Advisory Board

During her tenure at the University of South Florida Dr. Hunter was responsible for managing the patent portfolio associated with Alzamend’s two product candidates, AL001 and AL002


Lupin signs deal with Alvion for cardiometabolic drugs in Southeast Asia
Biotech | April 05, 2022

Lupin signs deal with Alvion for cardiometabolic drugs in Southeast Asia

Lupin is committed to providing new affordable treatment options to healthcare providers and patients


Good microbiome and probiotics key to good health
Healthcare | April 04, 2022

Good microbiome and probiotics key to good health

The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram


FirstCure, a healthcare startup that simplifies surgeries
Startup | April 04, 2022

FirstCure, a healthcare startup that simplifies surgeries

It aims to make the state-of-the-art modern and safe surgical care, typically available in super-speciality hospitals of big cities, accessible, affordable, standardized and integrated


Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar
Biotech | April 04, 2022

Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar

Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US


WHO suspends supply of Covaxin under Covax facility
News | April 03, 2022

WHO suspends supply of Covaxin under Covax facility

WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility


JBCPL buys Azmarda trademark for India at Rs 246 crore
News | April 03, 2022

JBCPL buys Azmarda trademark for India at Rs 246 crore

The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.